PNC Financial Services Group
BBIO icon

PNC Financial Services Group’s BridgeBio Pharma BBIO Stock Holding History

PNC Financial Services Group’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$510K Buy
6,849
+167
+2% +$11.7K ﹤0.01% 1771
2026
Q1 		$496K Buy
6,682
+1,231
+23% +$89.2K ﹤0.01% 1694
2025
Q4 		$417K Sell
5,451
-302
-5% -$19.8K ﹤0.01% 1797
2025
Q3 		$299K Buy
5,753
+3,561
+162% +$174K ﹤0.01% 2019
2025
Q2 		$94.7K Buy
2,192
+893
+69% +$32.5K ﹤0.01% 2743
2025
Q1 		$44.9K Buy
1,299
+200
+18% +$6.74K ﹤0.01% 3162
2024
Q4 		$30.2K Sell
1,099
-853
-44% -$22K ﹤0.01% 3351
2024
Q3 		$49.7K Buy
1,952
+1,114
+133% +$29.2K ﹤0.01% 3094
2024
Q2 		$21.2K Buy
838
+266
+47% +$7.27K ﹤0.01% 3450
2024
Q1 		$17.7K Sell
572
-25
-4% -$850 ﹤0.01% 3510
2023
Q4 		$24.1K Sell
597
-46
-7% -$1.38K ﹤0.01% 3330
2023
Q3 		$17K Hold
643
– – ﹤0.01% 3506
2023
Q2 		$11.1K Hold
643
– – ﹤0.01% 3835
2023
Q1 		$10.7K Sell
643
-116
-15% -$1.35K ﹤0.01% 3793
2022
Q4 		$5.78K Buy
759
+31
+4% +$297 ﹤0.01% 3958
2022
Q3 		$7K Hold
728
– – ﹤0.01% 3865
2022
Q2 		$7K Buy
728
+504
+225% +$4.21K ﹤0.01% 3899
2022
Q1 		$3K Buy
224
+142
+173% +$1.46K ﹤0.01% 4095
2021
Q4 		$1K Sell
82
-5,256
-98% -$222K ﹤0.01% 4256
2021
Q3 		$249K Buy
5,338
+144
+3% +$7.72K ﹤0.01% 2046
2021
Q2 		$316K Sell
5,194
-834
-14% -$47.6K ﹤0.01% 1929
2021
Q1 		$372K Buy
6,028
+1,832
+44% +$120K ﹤0.01% 1781
2020
Q4 		$299K Buy
4,196
+4,160
+11,556% +$201K ﹤0.01% 1820
2020
Q3 		$1K Sell
36
-5
-12% -$157 ﹤0.01% 3850
2020
Q2 		$1K Buy
+41
New +$1.25K ﹤0.01% 3830

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

PNC Financial Services Group's BBIO Position: Q2 2026 in Review

PNC Financial Services Group increased its BridgeBio Pharma (BBIO) stake by 2.5% in Q2 2026, buying an estimated $11.7K and bringing the position to 6,849 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #1771.

PNC Financial Services Group first reported a position in BBIO in Q2 2020 and has held it in 25 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • PNC Financial Services Group held 6,849 shares of BridgeBio Pharma worth $510K as of Q2 2026.
  • PNC Financial Services Group bought 167 BridgeBio Pharma shares in Q2 2026, an estimated $11.7K.
  • BridgeBio Pharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1771 holding.
  • PNC Financial Services Group first reported a position in BridgeBio Pharma in Q2 2020 and has held it in 25 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.